Monday, November 27, 2017

FDA announces guidelines that could hasten review of regenerative medicine products, such as stem cells

The U.S. Food and Drug Administration announced that it was issuing a new policy framework while also stepping up enforcement against products that raise safety concerns.

From: By Michelle Manchir http://www.ada.org/en/publications/ada-news/2017-archive/november/fda-announces-guidelines-of-regenerative-medicine-products

No comments:

Post a Comment